Work

APG808, an anti-IL-4Rα monoclonal antibody, demonstrates safety, extended half-life, and sustained inhibition of type 2 inflammatory biomarkers

Year: 2025

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2025.pa2474

Authors: Amol Kamboj, Erica Winter, Lauren Wood, Cecilia Hale, Sai Thankamony, Carl Dambkowski, Xiu Qin Lim

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416634870

Cites:

Cited by:

Related to: 10